Weight Loss Injections in the West Midlands: What Residents Actually Need to Know

Which injections are actually licensed for weight loss in the UK right now?

Two medicines hold a UK licence for weight management in adults. The first is tirzepatide, sold as Mounjaro, made by Eli Lilly. It works on two gut-hormone receptors simultaneously (GIP and GLP-1) which slows how quickly your stomach empties and reduces appetite. The second is semaglutide, sold as Wegovy by Novo Nordisk, which acts on the GLP-1 receptor alone. Both are given as once-weekly subcutaneous injections into the abdomen, thigh or upper arm, using a pre-filled pen.

A question our prescribers hear most weeks from people in the Midlands is whether Ozempic is an option for weight loss. It is not licensed for that purpose in the UK, Ozempic contains semaglutide but holds a licence only for type 2 diabetes. The medicine a prescriber would consider for weight management is Wegovy, which contains the same active ingredient at different doses. Getting that distinction right matters, because sourcing a diabetes medicine to use off-label for weight loss sits outside the regulated route and carries real risk.

If you want to understand how these two medicines compare in terms of trial results and mechanism, the guide to weight loss injection brands on our site sets it out clearly. For clinical evidence on tirzepatide specifically, NICE's appraisal TA1026 is the authoritative UK reference.

Can West Midlands residents get these injections on the NHS, and how long is the wait?

NHS access to weight loss injections across England, including the West Midlands, is being opened in phases under guidance from NHS England and NICE. As of summer 2026, tirzepatide is available through GP practices to adults with a BMI of 40 or above who have four or more qualifying conditions from a defined list: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. A second cohort covering BMI 35 to 39.9 with four or more of those conditions was activated in June 2026. Thresholds are 2.5 kg/m² lower for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds.

The practical reality is that GP participation in the scheme is optional, so whether your own practice in Coventry, Dudley or Walsall is offering it depends on local decisions. Even where a practice does participate, referral into a programme that includes the required dietary and activity support takes time. Wegovy on the NHS is routed through specialist weight management services, where waiting lists in many areas run to many months. For people who do not meet the NHS criteria yet, or who want to start sooner, a private weight loss injection through a properly regulated service is the alternative route. NHS eligibility never guarantees private eligibility, and the reverse is equally true: a private prescriber assesses you on the licensed criteria in the SmPC, which differ from NHS commissioning thresholds.

What should people in the West Midlands know about costs and sourcing safely?

Private pricing for weight loss injections has shifted considerably since Eli Lilly raised Mounjaro's UK list price in September 2025. Across the market, monthly costs typically range from around £149 to £375 depending on the dose and provider. A legitimate price includes a clinical assessment, the prescription, the medicine itself and delivery. If a price strips any of those out, it is worth asking why. For a fuller breakdown of what private treatment costs and what those figures include, the cost guide for weight loss injections is worth reading before you make any decisions.

The MHRA has issued repeated warnings about fake weight loss pens sold online, and in October 2025 enforcement teams raided the first UK site manufacturing counterfeit tirzepatide pens. The safest check is straightforward: any online pharmacy supplying these medicines must be registered with the GPhC. You can verify any pharmacy at pharmacyregulation.org/registers. Sellers offering these medicines without requiring a prescription, or advertising significant discounts, are a red flag. These are prescription-only medicines. That clinical gate exists for your protection, and it applies regardless of where in the West Midlands you live.

What are the realistic side effects and how are they managed?

The most common side effects of both Mounjaro and Wegovy are gastrointestinal: nausea, loose stools, constipation, reflux and burping. Most people find these are most noticeable in the first week or two after starting or increasing a dose, then settle. Fatigue and headache also appear in the trial data. Injection-site redness or bruising is possible; rotating sites between the abdomen, thigh and upper arm helps.

More serious effects are uncommon but need prompt attention. Severe stomach pain that radiates to the back (with or without vomiting) should prompt urgent medical help because of a known association with acute pancreatitis. The MHRA highlighted this specifically in a Drug Safety Update in January 2026. Gallbladder problems, dehydration from prolonged nausea, and signs of an allergic reaction are also reasons to seek care quickly rather than waiting for your next check-in.

Some people also ask whether these medicines affect mood. If you want to read more about what the evidence says on that question, the page on weight loss injections and mood covers it in detail. Any suspected side effect can be reported via the MHRA Yellow Card scheme, patients can report directly, not just clinicians. At the end of treatment or if you have aftercare queries, our support team is available seven days a week.

If you are ready to explore whether treatment is suitable for you, and you are curious about what the newest weight loss injection is called and how it compares to existing options, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician, with no referral needed and no waiting list to join.